INSM
Insmed Inc
$117.83
3.72 (3.06%) Today
— up— down
Market Cap
$25.73B-14.0%
Revenue (TTM)
$1.13B+185.8%
Net Income (TTM)
$-889,498,650
$-889,498,650EPS (TTM)
-4.10
-4.10Shares Out
216.75M
216.75MForward P/E
647.55
647.55Open
$117.83
$117.83Previous Close
$121.55
$121.55Day Range
$115.87 – $122.90
$115.87 – $122.9052-Week Range
$90.39 – $212.75
$90.39 – $212.75Beta
0.83
0.83Volume
2.67M
2.67MAvg Volume
3.12M
3.12MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout INSM
Related
News
N/AN/A
N/AN/A
Goldman Sachs Reinstates Buy on Insmed, Announces $188 Price Target
Benzinga · 3d ago
FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
Yahoo · 5d ago
Insmed: Expensive Stock, But Discount To Recent Highs Makes Bull Case
SeekingAlpha · 5d ago
Did FDA Priority Review of ARIKAYCE ENCORE Data Just Shift Insmed's (INSM) Investment Narrative?
Yahoo · 6d ago
FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
Yahoo · 6d ago